Online citations, reference lists, and bibliographies.
← Back to Search

The Proposed New International TNM Staging System For Malignant Pleural Mesothelioma: Application To Imaging.

E. Patz, V. Rusch, R. Heelan
Published 1996 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural mesothelioma (MPM) is an uncommon and usually fatal primary neoplasm of the pleura. In the past, response to standard therapy has been poor [1-3], but recent studies suggest that some patients may benefit from various therapeutic options, including surgical resection, combined technique treatment, and immunotherapy [4-7]. With improvements in therapy, an accurate, widely accepted staging system will be important in selecting homogeneous groups of patients for entry into clinical trials. Multiple staging systems have previously been proposed for MPM, but none are universally used [8].
This paper references
10.1016/0169-5002(94)00404-B
Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
L. Tammilehto (1995)
10.1016/0169-5002(92)90005-5
Malignant mesothelioma: prognostic factors in a prospective study of 98 patients
L. Tammilehto (1992)
10.1002/IJC.2910410409
Survival patterns for malignant mesothelioma: The seer experience
R. Spirtas (1988)
10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8
Activity of intrapleural recombinant gamma‐interferon in malignant mesothelioma
C. Boutin (1991)
10.1016/S0022-5223(19)35312-7
The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma.
V. Rusch (1988)
10.1200/JCO.1989.7.8.1157
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
10.1378/CHEST.89.4_SUPPLEMENT.225S
The new International Staging System for Lung Cancer.
C. Mountain (1987)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.2214/AJR.155.5.2120965
Malignant pleural mesothelioma: CT manifestations in 50 cases.
A. Kawashima (1990)
10.1200/JCO.1988.6.3.527
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
A. Alberts (1988)
10.1016/S0022-5223(19)36577-8
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
10.1016/S0022-5223(19)36578-X
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
D. Sugarbaker (1991)
10.1016/S0009-9260(82)80353-X
Computed tomography in the assessment of malignant mesothelioma of the pleura.
M. Law (1982)
10.1097/00004728-198907000-00011
MR Imaging of Malignant Pleural Mesothelioma
J. Lorigan (1989)
10.1200/JCO.1993.11.6.1172
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.
D. Sugarbaker (1993)



This paper is referenced by
10.1016/B978-0-443-06861-4.50100-3
TECHNIQUE OF EXTRAPLEURAL PNEUMONECTOMY FOR MALIGNANT PLEURAL MESOTHELIOMA
V. Rusch (2008)
10.3978/j.issn.2225-319X.2012.10.01
Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?
N. van Zandwijk (2012)
10.1016/S0003-4975(00)02394-8
Our contributions: scholarship revisited.
R. P. Scott (2001)
10.1016/j.cpet.2009.03.008
PET, CT, and MR Imaging for Assessment of Thoracic Malignancy: Structure Meets Function.
S. Katz (2008)
10.1016/S1879-8535(11)72795-7
Imagerie des tumeurs pleurales
Michel Brauner (2011)
Interreadervarianz bei der HRCT- und CXR-Befundung in einer Längsschnittstudie bei ehemals asbeststaubexponierten Personen
Tanja Maren Illa Carl (2005)
10.1016/S0761-8425(06)71784-3
3. Quel bilan pré-thérapeutique faut-il proposer à un patient porteur d’un mésothéliome pleural malin (MPM)?
J. Margery (2006)
10.1016/J.LUNGCAN.2005.05.025
Prognostic significance of Bax and Fas ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma.
N. Kokturk (2005)
10.1097/00005382-200605000-00006
Preoperative Evaluation of Patients With Malignant Pleural Mesothelioma: Role of Integrated CT-PET Imaging
M. Truong (2006)
10.1007/PL00002168
PleuramesotheliomTeil I: Geschichte, Epidemiologie, Klinik (Erscheinungsbild, Diagnostik)
Wolfgang Neumeister (2001)
10.1016/S0761-8417(06)75425-6
Le mésothéliome pleural : place de l’imagerie
F. Laurent (2006)
10.1053/SONC.2002.30228
The role of imaging in malignant pleural mesothelioma.
E. Marom (2002)
10.1016/B978-1-4160-5225-8.10002-9
Radiologic Imaging of Thoracic Abnormalities
C. J. Gutiérrez (2010)
10.1016/J.CCM.2006.02.001
Imaging of pleural disease.
N. R. Qureshi (2006)
10.1016/S0169-5002(00)00249-X
Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma.
S. Emri (2001)
10.1136/thorax.58.12.1077
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma
V. Gerbaudo (2003)
10.1016/J.LUNGCAN.2005.03.032
Consensus report: pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma.
J. Van Meerbeeck (2005)
ANALYSIS OF THE CASES OF DIAGNOSTICS OF MALIGNANT MESOTHELIOMA OF THE PLEURA
Амурский медицинский журнал (2017)
10.1017/9781316402009.004
Multi-modality Imaging of Pleural and Peritoneal Disease
J. Cunningham (2018)
10.2217/nnm.12.32
Nanoprobes for hybrid SPECT/MR molecular imaging.
Ripen Misri (2012)
10.14288/1.0071526
Molecular imaging of mesothelin expressing cancers
Ripen Misri (2010)
10.1097/01.CDR.0000282897.02516.56
The CT Appearances and Manifestations of Malignant Pleural Mesothelioma
Susan Cross (2007)
10.1016/j.crad.2009.03.010
CT appearances of pleural tumours.
H. Salahudeen (2009)
10.1097/00005382-200207000-00004
Imaging of thoracic occupational and environmental malignancies.
K. Garg (2002)
10.1148/RG.241035058
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
Z. Wang (2004)
10.1016/B978-0-7234-3496-2.00018-X
Neoplasms of the lungs, airways, and pleura
D. Hansell (2010)
10.12737/20127
FEATURES OF DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA
Ландышев (2016)
10.1016/J.RO.2004.04.005
Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma.
M. Truong (2004)
10.1007/s11547-006-0034-3
Imaging before and after multimodal treatment for malignant pleural mesothelioma
D. Fiore (2006)
10.1016/S0720-048X(00)00168-6
Malignant pleural disease.
B. Feragalli (2003)
10.3978/j.issn.2225-319X.2012.11.13
Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach.
V. Rusch (2012)
Imaging Neoplasms of the Thorax
J. Erasmus (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar